251 related articles for article (PubMed ID: 37336074)
1. Atorvastatin calcium alleviates 5-fluorouracil-induced intestinal damage by inhibiting cellular senescence and significantly enhances its antitumor efficacy.
Xia J; He S; Dai Q; Jia H; Ge Y; Zhou M; Wang X
Int Immunopharmacol; 2023 Aug; 121():110465. PubMed ID: 37336074
[TBL] [Abstract][Full Text] [Related]
2. Peficitinib ameliorates 5-fluorouracil-induced intestinal damage by inhibiting aging, inflammatory factors and oxidative stress.
He S; Xia J; Jia H; Dai Q; Chen C; Zhou Y; Wang XB
Int Immunopharmacol; 2023 Oct; 123():110753. PubMed ID: 37572505
[TBL] [Abstract][Full Text] [Related]
3. Artesunate alleviates 5-fluorouracil-induced intestinal damage by suppressing cellular senescence and enhances its antitumor activity.
Xia J; Dai QL; He S; Jia HJ; Liu XG; Hua H; Zhou M; Wang X
Discov Oncol; 2023 Jul; 14(1):139. PubMed ID: 37498338
[TBL] [Abstract][Full Text] [Related]
4. Metformin ameliorates 5-fluorouracil-induced intestinalinjury by inhibiting cellular senescence, inflammation, and oxidative stress.
Xia J; Chen J; Vashisth MK; Ge Y; Dai Q; He S; Shi YL; Wang XB
Int Immunopharmacol; 2022 Dec; 113(Pt A):109342. PubMed ID: 36327871
[TBL] [Abstract][Full Text] [Related]
5. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
[TBL] [Abstract][Full Text] [Related]
6. Qingjie Fuzheng Granule attenuates 5-fluorouracil-induced intestinal mucosal damage.
Zhang L; Jin Y; Peng J; Chen W; Lisha L; Lin J
Biomed Pharmacother; 2019 Oct; 118():109223. PubMed ID: 31325706
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin reverses the dysfunction of human umbilical vein endothelial cells induced by angiotensin II.
Dang H; Song B; Dong R; Zhang H
Exp Ther Med; 2018 Dec; 16(6):5286-5297. PubMed ID: 30542486
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q
Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706
[TBL] [Abstract][Full Text] [Related]
9. TBHQ attenuates ferroptosis against 5-fluorouracil-induced intestinal epithelial cell injury and intestinal mucositis via activation of Nrf2.
Deng S; Wu D; Li L; Li J; Xu Y
Cell Mol Biol Lett; 2021 Nov; 26(1):48. PubMed ID: 34794379
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer.
Tan X; Zhang Z; Liu P; Yao H; Shen L; Tong JS
Cell Death Dis; 2020 Dec; 11(12):1061. PubMed ID: 33311453
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
[TBL] [Abstract][Full Text] [Related]
12. Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features.
Was H; Czarnecka J; Kominek A; Barszcz K; Bernas T; Piwocka K; Kaminska B
Cancer Biol Ther; 2018 Jan; 19(1):63-75. PubMed ID: 29053388
[TBL] [Abstract][Full Text] [Related]
13. Enhancing 5-Fluorouracil Efficacy in a Primary Colorectal Cancer by Long-lasting Calcium Supplementation.
Jeong KY; Park M; Kim IU; Sim JJ; Kim HM
Anticancer Res; 2017 Jun; 37(6):2959-2964. PubMed ID: 28551633
[TBL] [Abstract][Full Text] [Related]
14. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
[TBL] [Abstract][Full Text] [Related]
15. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1.
Li C; Lu K; Yang C; Du W; Liang Z
J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
[TBL] [Abstract][Full Text] [Related]
17. Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer.
Kim HG; Kim CW; Lee DH; Lee JS; Oh ET; Park HJ
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491980
[TBL] [Abstract][Full Text] [Related]
18. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
[TBL] [Abstract][Full Text] [Related]
19. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
[TBL] [Abstract][Full Text] [Related]
20. An apple oligogalactan enhances the growth inhibitory effect of 5-fluorouracil on colorectal cancer.
Li Y; Fan L; Niu Y; Mian W; Zhang F; Xie M; Sun Y; Mei Q
Eur J Pharmacol; 2017 Jun; 804():13-20. PubMed ID: 28389232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
